Skip to main content
. 2023 Jan 13;32(4):1053–1067. doi: 10.1007/s11136-022-03322-9

Table 6.

Variation in algorithm outcome in AmbuFlex telePRO solutions 2011–2021

ICD10 group (solution ID) Algorithm outcome Severity grade variation
Total Green Yellow Red Severity gradea Total Within-patient Between-patient
n % % % Mean % %
B20 HIV disease (HV) 1370 13 58 30 2.0 0.90 35 65
C34 Lung cancer (PW) 8058 59 41 1.2 1.48 40 60
C43 Malignant melanoma (IM) 1193 17 83 2.5 1.14 48 52
C50 Breast cancer (AB) 3239 4 69 27 2.2 0.62 46 54
C61 Prostate cancer (PC) 2500 8 39 53 2.4 0.85 46 54
C61 Prostate cancer (P2/P3) 5050 7 57 36 2.2 0.76 45 55
C67 Bladder cancer (B3) 1515 16 10 74 2.4 1.10 50 50
C80 Cancer NOS (M3) 26,546 6 36 58 2.5 0.76 49 51
C80 Cancer NOS (IT/IN) 6060 19 55 26 1.9 1.01 48 52
E10 Type 1 DM (DM) 2183 4 33 63 2.6 0.69 36 64
E66 Obesity (FF) 102 2 97 1 2.0 0.37 45 55
G35 Multiple sclerosis (SC) 230 3 54 43 2.4 0.68 29 71
G40 Epilepsy (AE/E3) 28,608 18 63 20 1.8 0.94 42 58
G40 Epilepsy proxy (EP) 708 84 16 2.2 0.36 34 66
G47 Sleep disorders (SN) 941 1 66 33 2.3 0.53 33 67
G47 Sleep disorders (SA) 36,309 10 44 46 2.3 0.89 42 58
G47 Sleep disorders (NV) 1532 6 36 58 2.5 0.80 47 53
G91 Hydrocephalus (HC) 859 10 51 39 2.2 0.87 43 57
J44 COPD (KO) 14,249 35 43 22 1.5 1.19 38 62
J45 Asthma (AT/A5) 1121 12 10 78 2.5 1.01 36 64
K50 Crohn’s disease (IB/I2) 17,422 8 62 30 2.1 0.77 43 57
M05 Rheumatoid arhritis (RA/LG) 4136 27 54 19 1.6 1.07 46 54
M10 Gout (AU) 165 1 12 87 2.8 0.48 36 64
N18 Chronic kidney ds. (N2) 192 6 29 65 2.5 0.80 45 55
N80 Endometriosis (EN) 173 3 46 50 2.4 0.73 47 53
R52 Pain NOS (SM) (proxy) 999 52 39 8 1.0 1.12 41 59

Solutions with only one questionnaire per patient are not included

aSee Table 1